SCHEMBL25752840

SCHEMBL25752840

COC(=O)C[C@H](N)c1cc(C)ccc1F

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.40
ALDH1A1 P00352 1/20 0.40
HTT P42858 1/20 0.40
HSD17B10 Q99714 2/20 0.39
RAB9A P51151 4/20 0.39
NPC1 O15118 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
PKM P14618 1/20 0.39
KDM4E B2RXH2 2/20 0.38
POLB P06746 1/20 0.38
CTSA P10619 3/20 0.38
DPP4 P27487 2/20 0.37
ADRA2C P18825 1/20 0.37
ADRA1A P35348 1/20 0.37
ADRA1B P35368 1/20 0.37
MC4R P32245 2/20 0.36
HPGD P15428 1/20 0.36
ATM Q13315 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15497032 0.88 ALDH1A1 (0.46) MAPTALDH1A1HTTHSD17B10CTSA
SCHEMBL12525555 0.88 ALDH1A1 (0.46) MAPTALDH1A1HTTHSD17B10CTSA
SCHEMBL12492506 0.87 MAPT (0.40) MAPTALDH1A1HTTKDM4ECTSA
Hydrochloric Acid SCHEMBL29891870 0.87 ALDH1A1 (0.45) MAPTALDH1A1HTTHSD17B10CTSA
Hydrochloric Acid SCHEMBL29115990 0.87 ALDH1A1 (0.45) MAPTALDH1A1HTTHSD17B10CTSA
SCHEMBL24036692 0.85 GAA (0.38) MAPTALDH1A1HTTHSD17B10KDM4E
SCHEMBL24036820 0.83 CFTR (0.43) MAPTKDM4ECTSAMC4R
SCHEMBL24036573 0.83 ALDH1A1 (0.39) MAPTALDH1A1HTTPKMKDM4E
SCHEMBL25753758 0.83 ALDH1A1 (0.36) MAPTALDH1A1HTTSMN1; SMN2POLB
SCHEMBL25752841 0.82 MAPT (0.39) MAPTHTTHSD17B10KDM4ECTSA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192661-A1 1, 4, 5, 6-TETRAHYDROPYRIMIDINE-2-AMINE DERIVATIVE UBE CORPORATION (JP) 2023-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192661-A1 1, 4, 5, 6-TETRAHYDROPYRIMIDINE-2-AMINE DERIVATIVE DHFR, DPYD, CYP2D6 MAPT 3157/4885ALDH1A1 208/4885HTT 120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.